Stada Arzneimittel AGSAZX.N:GER

0.495 / 1.50%
Close in EURToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Oct 13 2015 16:35 BST.


On Tuesday, Stada Arzneimittel AG (SAZX.N:GER) closed at 32.40, 9.15% below its 52-week high of 35.67, set on Aug 06, 2015.

52-week range
Dec 17 2014
Aug 06 2015
Markit short selling activity
Day high32.78
Day low32.21
Previous close32.90
Average volume373.52k
Shares outstanding62.34m
Free float62.34m
P/E (TTM)39.19
Market cap2.05bn EUR
EPS (TTM)0.8394 EUR
Annual div (IAD)0.4859 EUR
Annual div yield (IAD)1.44%
Div ex-dateJun 04 2015
Div pay-dateJun 04 2015
Data delayed at least 15 minutes, as of Oct 13 2015 16:35 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Stada Arzneimittel AG-1.22%-1.19%-4.52%+12.68%+44.39%
DEUTSCHE BORSE DAX INDEX+1.31%-0.90%-17.95%+13.85%+55.92%
DE/HEALTH CARE-3.28%-6.00%-23.65%+14.04%+51.37%
Data delayed at least 15 minutes, as of Oct 13 2015 16:35 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.